K-Ras Inhibition of Migration and Invasion of Cancer Cells Overexpressing K-Ras

摘要

The invention relates to (a) a pharmaceutically effective amount of an epidemic (phlolologloucinol) of an effective ingredient, its salt, hydrate or solvent cargo; and (b) a pharmaceutically permissible composition, and a cancer prevention, treatment or total inhibition pharmaceutical composition of K-ras. The composition of the invention can prevent, treat or inhibit the cancer transmission of K-ras.